Population | Male (61) | Female (16) |
---|---|---|
Blood test | Â | Â |
White blood cells (× 109/L) (normal 4–10) | 5.3 ± 1.1 | 7.2 ± 2.1 |
Lymphocytes (× 109/L) (normal 1.1–4) | 2.3 ± 5.1 | 2.3 ± 4.2 |
C-reactive protein (mg/dL) (normal < 0.5) | 0.001 ± 0.001 | 0.001 ± 0.001 |
Ferritin (ng/mL) (normal 22–330) | 78.7 ± 56 | 34.8 ± 20 |
LDH (mU/mL) (normal 80–300) | 328 ± 61 | 264 ± 62 |
IL6 (pg/mL) (normal < 5.9) | 1.07 ± 0.72 | 1.6 ± 1.3 |
COVID IgG (BAU/mL) (positive > 7.1) | 34 ± 28 | 17.3 ± 8.8 |
COVID IgM (BAU/mL) (positive > 1.9) | 0.46 ± 0.4 | 1.11 ± 0.8 |
cTnT (pg/mL) (normal < 14) | 7.8 ± 10.4 | 3.4 ± 2 |
Echocardiography | Â | Â |
LV EDV (ml) | 124 ± 23 | 95 ± 11 |
LV EF (%) | 61 ± 9 | 65 ± 5 |
LAVI (ml/m2) | 29 ± 5 | 26 ± 5 |
RV basal diameter (mm) | 37 ± 4 | 34 ± 3 |
TAPSE (mm) | 25 ± 4 | 24 ± 3 |
PAPs (mmHg) | 24 ± 5 | 23 ± 3 |
Pericardial effusion | 0 | 2 |
Holter Monitor ECG 24Â h | Â | Â |
Heart rate (bpm) | 67 ± 12 | 73 ± 10 |
Supraventricular ectopic beat | 47 | 5 |
 < 100/24 h | 47 | 5 |
 100–500/24 h | 0 | 0 |
 > 500/24 h | 0 | 0 |
Ventricular ectopic beat | 27 | 5 |
 < 100/24 h | 25 | 5 |
 100–500/24 h | 2 | 0 |
 > 500/24 h | 0 | 0 |
Treadmill stress testing | Â | Â |
METs pre-COVID | 17.2 ± 2 | 15.1 ± 2 |
METs post-COVID | 17.7 ± 1 | 15.5 ± 3 |
ΔMETs | + 0.5 ± 0.2 | + 0.4 ± 0.3 |
Supraventricular ectopic beat | 4 | 0 |
 At rest | 1 |  |
 Exertion | 3 |  |
 Isolated | 3 |  |
 Repetitive | 1 |  |
Ventricular ectopic beat | 7 | 0 |
 At rest | 3 |  |
 Exertion | 3 |  |
 Isolated | 4 |  |
 Repetitive | 2 |  |
 LBBB configuration | 3 |  |
 RBBB configuration | 4 |  |